Tenaya Therapeutics (TNYA) Total Current Liabilities (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Total Current Liabilities of $16.8 million for Q1 2026, up 18.58% year-over-year from $14.2 million in Q1 2025, and up 8.71% quarter-over-quarter from $15.4 million in Q4 2025.
Tenaya Therapeutics (TNYA) Total Current Liabilities (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $16.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 18.58% year-over-year to $16.8 million; the TTM figure through Mar 2026 stood at $16.8 million (up 18.58% YoY), while the FY2025 annual figure was $15.4 million, down 3.37% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $16.8 million, up from $15.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $24.2 million in Q4 2022, with the low at $12.7 million in Q2 2025.
- The 5-year median for Total Current Liabilities is $17.7 million (2022), against an average of $17.8 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities soared 91.23% in 2022, then fell 29.73% in 2024.
- Tenaya Therapeutics' Total Current Liabilities stood at $24.2 million in 2022, then fell by 6.25% to $22.7 million in 2023, then dropped by 29.73% to $16.0 million in 2024, then decreased by 3.37% to $15.4 million in 2025, then advanced by 8.71% to $16.8 million in 2026.
- Business Quant data shows TNYA's Total Current Liabilities at $16.8 million in Q1 2026, $15.4 million in Q4 2025, and $13.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Tenaya Therapeutics | 150.58 Mn | 150.58 Mn | - | 19.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.02 Mn |
| Mar 31, 2026 | 16.78 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Sep 30, 2025 | 13.21 Mn |
| Jun 30, 2025 | 12.65 Mn |
| Mar 31, 2025 | 14.15 Mn |
| Dec 31, 2024 | 15.98 Mn |
| Sep 30, 2024 | 16.18 Mn |
| Jun 30, 2024 | 16.71 Mn |
| Mar 31, 2024 | 19.16 Mn |
| Dec 31, 2023 | 22.73 Mn |
| Sep 30, 2023 | 19.38 Mn |
| Jun 30, 2023 | 20.92 Mn |
| Mar 31, 2023 | 19.31 Mn |
| Dec 31, 2022 | 24.25 Mn |
| Sep 30, 2022 | 17.72 Mn |
| Jun 30, 2022 | 18.74 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 21.77 Mn |
| Sep 30, 2021 | 13.69 Mn |